Collegium Pharmaceutical
COLL
#5939
Rank
โ‚น105.72 B
Marketcap
โ‚น3,260
Share price
-1.02%
Change (1 day)
32.76%
Change (1 year)

Revenue for Collegium Pharmaceutical (COLL)

Revenue in 2025 (TTM): โ‚น68.34 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น74.68 Billion. an increase over the revenue in the year 2024 that were of โ‚น54.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Collegium Pharmaceutical from 2014 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น70.07 B29.35%
2024 โ‚น54.16 B14.81%
2023 โ‚น47.18 B22.9%
2022 โ‚น38.39 B86.29%
2021 โ‚น20.60 B-9.11%
2020 โ‚น22.67 B7.16%
2019 โ‚น21.15 B7.91%
2018 โ‚น19.60 B978.37%
2017 โ‚น1.81 B1463.78%
2016 โ‚น0.11 B
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
United Therapeutics
UTHR
โ‚น304.52 B 307.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
โ‚น2.06 B-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น348.69 B 366.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
โ‚น1.00 B-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA